LTIP120A - Prevetive means against cancer - Google Patents

Prevetive means against cancer

Info

Publication number
LTIP120A
LTIP120A LTIP120A LTIP120A LTIP120A LT IP120 A LTIP120 A LT IP120A LT IP120 A LTIP120 A LT IP120A LT IP120 A LTIP120 A LT IP120A LT IP120 A LTIP120 A LT IP120A
Authority
LT
Lithuania
Prior art keywords
against cancer
prevetive
stakliškės
bočiai
mead
Prior art date
Application number
LTIP120A
Other languages
Lithuanian (lt)
Inventor
Valentas SEMĖNAS
Bronislava Vida SEMĖNIENĖ
Janina Valavičienė
Juozas VALAVIČIUS
Original Assignee
Valentas SEMĖNAS
Bronislava Vida SEMĖNIENĖ
Janina Valavičienė
Juozas VALAVIČIUS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valentas SEMĖNAS, Bronislava Vida SEMĖNIENĖ, Janina Valavičienė, Juozas VALAVIČIUS filed Critical Valentas SEMĖNAS
Priority to LTIP120A priority Critical patent/LT3004B/en
Publication of LTIP120A publication Critical patent/LTIP120A/en
Publication of LT3004B publication Critical patent/LT3004B/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Išradimas priklauso prie profilaktinių priemonių organizmo sustiprinimui, konkrečiai, profilaktiškai apsaugojančių nuo vėžinių susirgimų. Tai pasikiama pirmą kartą panaudojant žinomus midaus gėrimus "Stakliškės" arba "Bočiai" kaip profilaktinę priemonę prieš vėžinius susirgimus. Bandymų rezultatai leidžia teigti, kad midaus gėrimai "Stakliškės" arba "Bočiai" pasižymi vidutiniu priešvėžiniu aktyvumu (patikimai stabdo Sarkomos 45 augimą 44-45%, o Liuiso plaučių karcinomos 47-55%), teigiamai veikia blužnies masę (padidino blužnies masę 42,8%).The invention relates to prophylactic measures for the strengthening of the body, specifically, to prevent cancer. This is due to the first use of known mead drinks "Stakliškės" or "Bočiai" as a preventive measure against cancer. The results of the tests suggest that mead drinks "Stakliškės" or "Bočiai" have an average anticancer activity (reliably inhibits the growth of Sarkom 45 by 44-45%, and Liuiso lung carcinoma by 47-55%), positively affects spleen mass (increased spleen mass 42, \ t 8%).

LTIP120A 1992-09-09 1992-09-09 Preventive means against cancer. LT3004B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
LTIP120A LT3004B (en) 1992-09-09 1992-09-09 Preventive means against cancer.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LTIP120A LT3004B (en) 1992-09-09 1992-09-09 Preventive means against cancer.

Publications (2)

Publication Number Publication Date
LTIP120A true LTIP120A (en) 1994-03-25
LT3004B LT3004B (en) 1994-08-25

Family

ID=19721047

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP120A LT3004B (en) 1992-09-09 1992-09-09 Preventive means against cancer.

Country Status (1)

Country Link
LT (1) LT3004B (en)

Also Published As

Publication number Publication date
LT3004B (en) 1994-08-25

Similar Documents

Publication Publication Date Title
MY118068A (en) Protein kinase c inhibitor
MX9707431A (en) Protein kinase c inhibitors.
CA2022444A1 (en) Lhrh analogs
CA2137203A1 (en) Protein kinase c inhibitors
UA39158C2 (en) derivatives of N4-oxycarbonyl- 5'-deoxy-5-fluorocytidine and pharmaceutical preparation based thereon
NZ333302A (en) Substituted 6,5-hetero-bicyclic derivatives for the prevention or inhibition of a disorder that can be treated by antagonising corticotropin releasing factor
IL127244A (en) Substituted amines, methods of their preparation and pharmaceutical compositions containing them
MX9604145A (en) Methods and compositions useful for inhibition of angiogenesis.
MY121047A (en) Bicyclo [2.2.1] heptanes and related compounds
ES8801790A1 (en) Indole derivative
MY125602A (en) Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
MXPA99001870A (en) Non-peptide tachykinin receptor antagonists.
DE3162004D1 (en) Metal chelates of 1,4-bis(substituted-amino)-5,8-dihydroxy-anthraquinones
CA2152771A1 (en) 7-o-ethers of taxane derivatives
EP0369685A3 (en) Fluoxetine analog
MY124078A (en) Eletriptan hydrobromide monohydrate
EP0328090A3 (en) Lhrh analogs
MY109640A (en) Antitumor compositions and methods of treatment
LTIP120A (en) Prevetive means against cancer
FI991441A0 (en) Peptide compounds, especially LHRH antagonists
WO1999047150A3 (en) A pharmaceutical composition containing ezrin mutated on tyrosine 353
TW371661B (en) Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides
IL95902A0 (en) Prostacyclin derivatives and pharmaceutical compositions containing the same
BG105549A (en) Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
TW374764B (en) Antitumor and antileukaemic compounds, their preparation and pharmaceutical composition containing them